BIOG-B.STBIOG-B.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +22.52% | -0.96% | +5.36% | +7.46% | +20.76% |
| Gross Profit Growth | +14.71% | +0.95% | +3.46% | +9.07% | +25.25% |
| EBITDA Growth | +26.09% | -31.49% | -19.15% | -11.02% | +7.08% |
| Operating Income Growth | +28.39% | -20.77% | -23.26% | +117.18% | +17.04% |
| Net Income Growth | +21.63% | -34.18% | -20.81% | +80.00% | +20.57% |
| EPS Growth | +20.90% | -34.71% | -20.91% | +80.56% | +20.99% |
| EPS Diluted Growth | +20.90% | -34.71% | -20.91% | +80.56% | +20.99% |
| Weighted Average Shares Growth | +0.18% | +0.18% | +0.18% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | +0.18% | +0.17% | +0.16% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -15.23% | -31.21% | -35.22% | +10.12% | -19.10% |
| Free Cash Flow Growth | -5.62% | -18.84% | -34.97% | +12.24% | -18.66% |
| Receivables Growth | +110.13% | +0.00% | +0.00% | +0.00% | -100.00% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.82% | -18.05% | -24.64% | -21.94% | -21.45% |
| Book Value per Share Growth | -15.24% | -18.09% | -26.83% | -24.80% | -23.77% |
| Debt Growth | -19.32% | +0.00% | +0.00% | +0.00% | -100.00% |
| R&D Expense Growth | +17.90% | -9.74% | +13.29% | -63.75% | +8.92% |
| SG&A Expenses Growth | +24.17% | +12.99% | +29.58% | +20.90% | +19.55% |